13314-30-2

Basic information

• Product Name: TRANS-1,3,5-TRIHYDROXYCYCLOHEXANE
• Synonyms: TRANS-1,3,5-TRIHYDROXYCYCLOHEXANE
• CAS NO: 13314-30-2
• Molecular Formula: C6H12O3
• Molecular Weight: 132.16
• Mol File: 13314-30-2.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 302.1°Cat760mmHg
• Flash Point: 154.2°C
• Appearance: /
• Density: 1.356g/cm³
• Vapor Pressure: 9.86E-05mmHg at 25°C
• Refractive Index: 1.58
• CAS DataBase Reference: TRANS-1,3,5-TRIHYDROXYCYCLOHEXANE(CAS DataBase Reference)
• NIST Chemistry Reference: TRANS-1,3,5-TRIHYDROXYCYCLOHEXANE(13314-30-2)
• EPA Substance Registry System: TRANS-1,3,5-TRIHYDROXYCYCLOHEXANE(13314-30-2)

Safety Data

• Hazardous Substances Data: 13314-30-2(Hazardous Substances Data)

Usage

InChI:InChI=1/C6H12O3/c7-4-1-5(8)3-6(9)2-4/h4-9H,1-3H2/t4-,5-,6-

Upstream product

• 108-73-6 3,5-dihydroxyphenol 
• 7732-18-5 water 
• 91-17-8 decalin 
• 64-17-5 ethanol 

Downstream Products

• 157371-80-7 3-(bromomethyl)-2,4,10-trioxaadamantane 
• 281-33-4 2,8,9-trioxa-1-phospha-adamantane 
• 875-12-7 2,8,9-trioxa-1-phospha-adamantane-1-oxide 
• 64747-25-7 cis,cis-1,3,5-cyclohexanetritosylate 
• 93563-91-8 3-Amino-2,4,10-trioxaadamantan 
• 93563-95-2 2,4,10-Trioxaadamantan-3-carbonylchlorid 
• 93563-99-6 (2,4,10-Trioxaadamant-3-yl)trimethylammonium-iodid 
• 281-33-4 2,8,9-trioxa-1-phospha-adamantane 
• 6287-90-7 11-bromo-undecanoic acid methyl ester 
• 6271-23-4 11-bromoundecanoic acid ethyl ester 
• 88803-63-8 1-Brom-4-(2,4,10-trioxatricyclo<3.3.1.1^3,7>dec-3-yl)decan 
• 54049-24-0 methyl 7-bromoheptanoate 
• 88784-99-0 1-Brom-4-(2,4,10-trioxatricyclo<3.3.1.1^3,7>dec-3-yl)hexan 
• 91362-62-8 3-(2,4-dimethylphenyl)-2,4,10-trioxaadamantane 

Relevant articles and documents

Concise total synthesis of AB5046A and AB5046B

Two naturally occurring rare 5-oxo β-triketones, AB5046A and AB5046B, were efficiently synthesized in five linear steps with overall yields of 36% and 28%, respectively. The synthetic strategy highlighted the readily preparation of the key intermediate, 3

Optically active phenoxypropionic esters

Optically active compounds of the formula I STR1 where R is C1 -C12 -alkyl or -perfluoroalkyl in which one or two non-adjacent CH2 or CF2 groups can also be replaced by --O-- and/or --CO-- and/or --CO--O-- and/or --CH=CH-- and/or --CH-halogen-- and/or --CHCN-- and/or --0--CO--CH-halogen-- and/or --O--CO--CHCN--, or is C1 -C12 -alkyl which can have a terminal chemically reactive group and in which a CH2 group can be replaced by --O--, A1 and A2 are each, independently of one another, 1,4-phenylene which is unsubstituted or substituted by one or two F and/or Cl and/or Br atoms and/or CH3 groups and/or CN groups and in which one or two CH groups can also be replaced by N, 1,4-cyclohexylene in which one or two non-adjacent CH2 groups can also be replaced by --O-- and/or --S--, 1,4-piperidinediyl, 1,4-bicyclo[2.2.2]octylene, 2,6-naphthalenediyl, decahydro-2,6-naphthalenediyl or 1,2,3,4-tetrahydro-2,6-naphthalenediyl, A3 is unsubstituted or substituted phenyl, Z is --CO--O--, --O--CO--, --CH2 CH2 --, --OCH2 --, --CH2 O--, --C C-- or a single bond and m is 0, 1, 2 or 3.

6-Substituted-4-hydroxy-tetrahydropyran-2-ones

6-Substituted-4-hydroxy-tetrahydropyran-2-ones, useful as anti-atherosclerotic agents, are obtainable by the process of the invention. The 6-substituents have a phenyl, naphthyl, tetrahydronaphthyl or indolyl nucleus bound through an ethenyl unit. The inv